This is a preview of subscription content, log in via an institution to check access.
Notes
based on the optimal duration of initial pharmacological treatment (8 weeks) and maintenance treatment (26 weeks) and to allow for switching to second-line treatment in patients not responding to 8 weeks of first-line treatment
Costs (2011 values) included those associated with drug acquisition, visits to general practitioners, and other health and social care incurred by patients not responding to treatment or relapsing following response
Reference
Mavranezouli I, et al. The Cost Effectiveness of Pharmacological Treatments for Generalized Anxiety Disorder. PharmacoEconomics : 20 Mar 2013. Available from: URL: http://dx.doi.org/10.1007/s40273-013-0031-z
Rights and permissions
About this article
Cite this article
Sertraline best option for GAD in the UK. PharmacoEcon Outcomes News 675, 7 (2013). https://doi.org/10.1007/s40274-013-0285-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0285-x